🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

29 recruiting trials

for COVID-19 Vaccines

A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations NCT06585241Phase 46 sites📍 Atlanta📍 Decatur📍 Baton Rouge ModernaTX, Inc. · Tests: mRNA-1273 Variant-containing Formulation Testimonials and Navigation in Rheumatology NCT06469788NA4 sites📍 Birmingham📍 Evanston📍 Boston University of Alabama at Birmingham · Tests: Video comprised of AIRD patient narratives on COVID-19 vaccination thoughts and experiences, Video on the importance of… A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age NCT07730450Phase 45 sites📍 Walnut Creek📍 Miami Lakes📍 Honolulu BioNTech SE · Tests: BNT162b2 Vaccine, Tdap Vaccine Genomics and COVID-19 Vaccine Adverse Events NCT05212792n/a1 site📍 Vancouver University of British Columbia · Tests: COVID-19 vaccines COVID-19 Vaccines Safety Tracking (CoVaST) NCT04834869n/a14 sites📍 Philadelphia📍 Hamilton📍 Split Masaryk University · Tests: BNT162b2, mRNA-1273, AZD1222, CoronaVac, Sinopharm Comparison of the Immune Response to Natural COVID-19 Infection and Vaccination NCT04706390n/a1 site📍 Bergen University of Bergen · Tests: covid-19 vaccine An Experimental Medicine Multicenter Trial to Evaluate the Safety and Immunogenicity of Experimental Versus Authorized SARS-CoV-2 Vaccine Candidates as a Booster Dose in Healthy Participants Previously Vaccinated With Authorized mRNA SARS-CoV-2 Vaccines. NCT07605520EARLY Phase 13 sites📍 Créteil📍 Paris📍 Lausanne ANRS, Emerging Infectious Diseases · Tests: CD40.RBDv vaccine adjuvanted with Hiltonol®, CD40.Pan.CoV vaccine adjuvanted with Hiltonol®, Comirnaty® vaccine, Nuvaxo… Connecting Friends and Health Workers to Boost COVID-19 Vaccination in Latino Communities NCT06128928NA1 site📍 Baltimore Johns Hopkins University · Tests: REDES, Control A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults NCT07536308Phase 16 sites📍 Decatur📍 Baltimore📍 Boston National Institute of Allergy and Infectious Diseases (NIAI… · Tests: OCU500 Study Comparing Safety and Immunogenicity of Intranasal COVID-19 Vaccine and mRNA Booster in Healthy Adults NCT06821126Phase 1, Phase 25 sites📍 Dijon📍 Lyon📍 Paris ANRS, Emerging Infectious Diseases · Tests: LVT-001, Cormirnaty Researchers At UC San Diego Are Learning About the Benefits of Human Milk and How It Influences Infant and Child Health NCT05553743n/a1 site📍 San Diego University of California, San Diego · Tests: COVID-19 Exposure, Antibiotic COVID-19 Vaccine-induced Inflammatory Heart Disease Prevalence Registry NCT05046002n/a1 site📍 Ottawa Ottawa Heart Institute Research Corporation Dissecting Human Immune Responses to Infection With Influenza or SARS-CoV-2 NCT06848309n/a1 site📍 St Louis Washington University School of Medicine · Tests: Bronchoscopy Covid-19 and Influenza Oral Vaccine Study NCT06355232Phase 11 site📍 Adelaide Vaxine Pty Ltd · Tests: Covid-19 vaccine, Influenza vaccine COVID-19 Impact on RSV Emergency Presentations NCT04959734n/a1 site📍 Leicester University Hospitals, Leicester Thymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of Vaccine Response Among Older Adults Receiving Booster Doses of COVID-19 Vaccine NCT06821100Phase 11 site📍 Houston The Methodist Hospital Research Institute · Tests: Thymalfasin (Thymosin alpha 1, Ta1) A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults NCT07464314Phase 112 sites📍 Anniston📍 Little Rock📍 Fair Oaks GlaxoSmithKline · Tests: Investigational mRNA Seasonal Flu/COVID-19 Combination (Flu/COVm) Vaccine, Licensed Seasonal Influenza Vaccine, License… Effect of Messaging on Pragmatic Outcomes Within an Integrated Healthcare System NCT07838038NA1 site📍 Pasadena Kaiser Permanente · Tests: Vaccine choice message, Vaccine choice + platform-framed message, Vaccine choice + HCP trust-framed message, Vaccine ch… Clinical Laboratory Evaluation, Assessment of Symptoms and Recovery in Patients With Post-COVID-19-Vaccination Syndrome NCT07400848n/a1 site📍 Bern University of Bern · Tests: Blood sampling and analysis, The continuous Reactive Hyperemia Index (InRHI) measured by EndoPAT COVID-19 Vaccine Effectiveness Against Recurrent Infection Among Lung Cancer Patients and Biomarker Research NCT06168032NA1 site📍 Beijing Peking Union Medical College Hospital · Tests: Any Chinese government-recommended COVID-19 booster vaccine COVID-19 Booster and IIV Schedule in Immunocompromised Hosts NCT06599658Phase 23 sites📍 Montreal📍 Montreal📍 Montreal McGill University Health Centre/Research Institute of the M… · Tests: Inactivated influenza vaccine (IIV) at baseline, COVID-19 Vaccines at a 3-month interval, Inactivated influenza vaccine… Safety and Immunogenicity of a Sub-unit Protein CD40.RBDv Bivalent COVID-19 Vaccine, Adjuvanted or Not, as a Booster in Volunteers. NCT06255626Phase 1, Phase 22 sites📍 Créteil📍 Paris ANRS, Emerging Infectious Diseases · Tests: CD40.RBDv vaccin (SARS-Cov2 Vaccin) A Study of COVID-19 Vaccine(s) in Children and Adults NCT07798648Phase 314 sites📍 Homestead📍 Miami Lakes📍 Atlanta BioNTech SE · Tests: BNT162b2, BNT162b2, BNT162b2 Study of a Recombinant Spike COVID-19 Vaccine With Matrix-M in Older Adults and People at Increased Risk of Severe COVID-19 NCT07861542Phase 420 sites📍 Fair Oaks📍 Doral📍 Atlanta Sanofi · Tests: Omicron Subvariant-Based SARS-CoV-2 Recombinant Spike Vaccine Adjuvanted With Matrix-M Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients NCT05571735n/a1 site📍 Mae Ramat University of Oxford · Tests: Pfizer-BioNTech COVID-19 vaccine, AstraZeneca vaccine, Janssen Ad26.COV2.S COVID-19 vaccine A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses NCT06810934Phase 1, Phase 22 sites📍 Los Angeles📍 San Francisco Kara Chew · Tests: CoTend-BXBB (SARS2-30404), CoTend-s3BXBB (SARS2-17032), Placebo Understanding Immunity to the Flu Vaccine in COVID-19 Patients NCT04579588n/a1 site📍 Palo Alto Stanford University · Tests: Flu shot Addressing Vaccine Acceptance in Carceral Settings Through Community Engagement NCT05796505NA1 site📍 Schwenksville Yale University · Tests: ADVANCE Steering Committee interventions A Trial of a Next Generation COVID-19 Vaccine Delivered by Inhaled Aerosol NCT06381739Phase 22 sites📍 Halifax📍 Hamilton McMaster University · Tests: ChAd-triCoV/Mac, Control
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy